Sheng-lin H. Ma - Publications

Hyperthermia correlates with low incidence of radiation pneumonitis after thoracic radiotherapy: a retrospective study.

Journal: BMC cancer

Published: May 31, 2025

Correction: Efficacy of afatinib, an irreversible ErbB family blocker, in the treatment of intracerebral metastases of non-small cell lung cancer in mice.

Journal: Acta pharmacologica Sinica

Published: April 09, 2025

Development and validation of an individual risk prediction tool for severe respiratory syncytial virus infection among children under five years in China

Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]

Published: August 14, 2024

Revisiting the role of pregnancy zone protein (PZP) as a cancer biomarker in the immunotherapy era.

Journal: Journal of translational medicine

Published: May 10, 2024

ITGB4 is a prognostic biomarker and correlated with lung adenocarcinoma brain metastasis.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 13, 2024

Current status of surveillance systems for human respiratory syncytial virus

Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]

Published: February 25, 2024

Oleandrin enhances radiotherapy sensitivity in lung cancer by inhibiting the ATM/ATR-mediated DNA damage response.

Journal: Phytotherapy research : PTR

Published: January 12, 2024

Inflammation-related molecular signatures involved in the anticancer activities of brigatinib as well as the prognosis of EML4-ALK lung adenocarcinoma patient.

Journal: Acta pharmacologica Sinica

Published: September 04, 2023

CISD2 promotes lung squamous carcinoma cell migration and invasion via the TGF-β1-induced Smad2/3 signaling pathway.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: February 14, 2023

Erratum: Jiedu Sangen Decoction Reverses Epithelial-to-mesenchymal Transition and Inhibits Invasion and Metastasis of Colon Cancer via AKT/GSK-3β Signaling Pathway: Erratum.

Journal: Journal of Cancer

Published: January 06, 2023

DNA methylation profiling to determine the primary sites of metastatic cancers using formalin-fixed paraffin-embedded tissues.

Journal: Nature communications

Published: November 28, 2022

Polydopamine nanomotors loaded indocyanine green and ferric ion for photothermal and photodynamic synergistic therapy of tumor.

Journal: Journal of colloid and interface science

Published: July 23, 2022